BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 22, 2026
Home » Authors » John Fox

Articles by John Fox

New blood test developed for early Alzheimer's diagnosis

April 22, 2019
By John Fox
South Korean neuroscientists and bioengineers have successfully developed a new blood test for Alzheimer's disease (AD), which was shown to be capable of rapidly distinguishing between AD patients and individuals with normal cognition, with selectivity and sensitivity exceeding 90%.
Read More

New blood test developed for early Alzheimer's diagnosis

April 19, 2019
By John Fox

Researchers unveil first anisotropic knee meniscus engineered from stem cells

April 18, 2019
By John Fox

Researchers unveil first anisotropic knee meniscus engineered from stem cells

April 18, 2019
By John Fox
A tissue-engineered knee meniscus, seeded with mesenchymal stem cells (MSCs) under biomechanical and biochemical stimuli in vitro, has been shown to promote anisotropy and have a functional chondroprotective effect on the knee, a Chinese study reported in the April 10, 2019, issue of Science Translational Medicine.
Read More

Glioblastoma-on-a-chip predicts therapeutic responses

April 3, 2019
By John Fox
Korean bioengineers and neurosurgeons have developed a novel patient-specific bioprinted tumor-on-a-chip model of glioblastoma, which might prove useful for identifying optimal treatments for patients resistant to standard first-line therapies.
Read More

Glioblastoma-on-a-chip used to predict therapeutic response

April 1, 2019
By John Fox

Glioblastoma-on-a-chip predicts therapeutic responses

April 1, 2019
By John Fox
Korean bioengineers and neurosurgeons have developed a novel patient-specific bioprinted tumor-on-a-chip model of glioblastoma, which might prove useful for identifying optimal treatments for patients resistant to standard first-line therapies.
Read More

Eye patches now for drug delivery, not just pirates

Nov. 14, 2018
By John Fox
A miniature eye patch delivering drugs directly into the eye for safer and more effective treatment of ocular diseases has been reported by researchers at Singapore's Nanyang Technological University in the Nov. 6, 2018, edition of Nature Communications.
Read More

Eye patches now for drug delivery, not just pirates

Nov. 9, 2018
By John Fox

Eye patches now for drug delivery, not just pirates

Nov. 7, 2018
By John Fox
A miniature eye patch delivering drugs directly into the eye for safer and more effective treatment of ocular diseases has been reported by researchers at Singapore's Nanyang Technological University in the Nov. 6, 2018, edition of Nature Communications.
Read More
Previous 1 2 … 16 17 18 19 20 21 22 23 24 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • Alicorn synthesizes new AAK1 inhibitors

    BioWorld Science
    Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
  • Illustration of glucose in the blood stream

    CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

    BioWorld Science
    Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
  • Illustration of a child's brain

    Saniona reports preclinical data for SAN-2668

    BioWorld Science
    Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
  • CC-3 antibody shows antitumoral activity in penile cancer

    BioWorld Science
    Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing